Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Active, not recruiting

• Conditions: Papillary Carcinoma
• Interventions: Other: Questionnaire

• Registration Number: NCT05873361
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients.

The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-15
• Study First Submitted: 2023-05-15
• Study First Submitted QC: 2023-05-15
• Study First Posted: 2023-05-24
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-19
• Last Update Posted: 2023-06-22
• Primary Completion: 2027-05-15
• Study Completion: 2027-05-15

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci <10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017.
• Non opposition patient
• Affiliation to a social security scheme

Exclusion Criteria

• Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement.
• Patient under guardianship, curators or safeguard of justice

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Adult patients with a papillary microcarcinoma asymptomatic	Questionnaire	Adult patients who have had a papillary microcarcinoma asymptomatic and who are followed.

Primary Outcome Measures

Name	Time	Method
Overall survival	10 years	Review of medical record

Secondary Outcome Measures

Name	Time	Method
Disease control rate	10 years	No recurrence clinically detected or by additional examen
Surgical complications rate	10 years	Dysphonia and hypocalcemia
Anxiety evaluation	1 month	Likert scale
Detection of recurrence rate	10 years	Recurrence detection by additional examen
Recovery surgical or iratherapie recovery rate	10 years	Anatomopathologic analysis
Prognostics survival criteria	1 month	Age during surgical

Trial Locations

Locations (1)

UHToulouse; 🇫🇷 Toulouse, France